Oncology & Cancer

Drug that targets key mutation found to shrink some tumors

A team of researchers affiliated with several institutions in the U.S. and Australia (and sponsored by pharmaceutical company Amgen Research) has found that a drug they optimized to target a protein produced due to mutations ...

Medical research

More evidence that blood tests can detect the risk of Alzheimer's

A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer's ...

Medical research

The immune system's fountain of youth

If only we could keep our bodies young, healthy and energetic, even as we attain the wisdom of our years. New research at the Weizmann Institute of Science suggests this dream could be at least partly obtainable in the future. ...

Neuroscience

Brain signals for drug screening

There are still comparatively few treatments available for brain diseases. Among other reasons, this is due to the difficulty of developing new drugs, as it is not easy to establish the effects and side effects of a substance ...

Oncology & Cancer

Blood test picks out prostate cancer drug resistance

Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.

page 7 from 40